#Scoliosis management market trends | Explore Tumblr Posts and Blogs

shubhampawrainfinium · 1 month

Text

"Spinal Fusion Devices: Genuine Market Growth or Just a Painful Reality?"

Introduction

Spinal fusion devices are vital in the management of spinal disorders such as degenerative disc disease, spinal fractures, and scoliosis. These devices stabilize the spine by fusing vertebrae to promote healing and restore function. The market for spinal fusion devices is expanding due to an increasing incidence of spinal disorders, advancements in technology, and an aging population. This report provides a detailed analysis of the spinal fusion devices market, focusing on market dynamics, regional trends, segmentation, competitive landscape, and future outlook.

Market Dynamics

Drivers

Rising Prevalence of Spinal Disorders: The increasing occurrence of spinal conditions due to aging, sedentary lifestyles, and injuries drives demand for spinal fusion procedures and devices. As the global population ages, the need for effective spinal treatments is growing.

Technological Advancements: Innovations in spinal fusion technology, including minimally invasive techniques and advanced implant materials, enhance the efficacy and safety of surgeries. These advancements stimulate market growth by improving patient outcomes and expanding device applications.

Growing Aging Population: The expanding elderly population contributes to a higher incidence of age-related spinal disorders. This demographic trend fuels demand for spinal fusion devices as part of comprehensive spinal care.

Challenges

High Costs: The cost associated with spinal fusion surgeries and devices is significant, which can limit accessibility, particularly in cost-sensitive regions. High expenses can constrain market growth and adoption.

Surgical Risks and Complications: Risks such as infection, hardware failure, and adjacent segment degeneration pose challenges to spinal fusion procedures. These complications can affect patient outcomes and influence the adoption of spinal fusion devices.

Regulatory and Reimbursement Issues: Navigating complex regulatory requirements and obtaining reimbursement for spinal fusion procedures can be challenging. Variations in regulatory standards and reimbursement policies impact market dynamics.

Opportunities

Emerging Markets: Expanding healthcare infrastructure and rising incomes in emerging markets like Asia-Pacific and Latin America present significant growth opportunities for spinal fusion device manufacturers. These regions are experiencing increased demand for advanced spinal care solutions.

Innovative Product Development: Continued innovation in spinal fusion devices, including the development of advanced biomaterials and minimally invasive technologies, offers opportunities for differentiation and market expansion.

Increasing Awareness: Growing awareness of spinal health and advancements in surgical techniques drive demand for effective spinal fusion solutions. Educational initiatives can further promote the benefits of spinal fusion devices.

Sample Pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/1656

Regional Analysis

North America: Dominates the market due to advanced healthcare systems, high prevalence of spinal disorders, and substantial investment in medical technology. The U.S. and Canada lead with significant adoption of advanced spinal fusion technologies.

Europe: Features a mature market with strong demand driven by established healthcare infrastructure and increasing focus on improving surgical outcomes. Germany, France, and the UK are key markets.

Asia-Pacific: Experiencing rapid growth due to rising healthcare expenditures, expanding medical infrastructure, and increasing awareness of spinal disorders. China, India, and Japan are major markets with high potential.

Latin America: Shows growing demand for spinal fusion devices as healthcare facilities improve and patient awareness increases. Brazil and Mexico are leading markets.

Middle East & Africa: Developing market with increasing investments in healthcare infrastructure. Although still emerging, the region is expected to see growth in demand for spinal fusion devices.

Market Segmentation

By Device Type:

Spinal Fusion Implants (Pedicle Screws, Rods, Cages)

Bone Graft Substitutes

Artificial Discs

Others

By Procedure:

Anterior Lumbar Interbody Fusion (ALIF)

Posterior Lumbar Interbody Fusion (PLIF)

Transforaminal Lumbar Interbody Fusion (TLIF)

Cervical Fusion

Others

By End User:

Hospitals

Orthopedic Clinics

Spine Specialty Centers

Others

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Competitive Landscape

Market Share of Large Players: Major companies like Medtronic, Johnson & Johnson, and Stryker hold significant market shares due to their extensive product portfolios and global presence.

Price Control: Large players have considerable influence over pricing due to their market dominance. However, competition is strong, and pricing is affected by factors such as technology and regional market conditions.

Competition from Small and Mid-Size Companies: Smaller and mid-size firms challenge larger players by offering specialized or innovative products. These companies often focus on niche markets or unique solutions.

Key Players:

Medtronic plc

Johnson & Johnson

Stryker Corporation

Zimmer Biomet Holdings, Inc.

NuVasive, Inc.

Report Overview: https://www.infiniumglobalresearch.com/reports/global-spinal-fusion-devices-market

Future Outlook

New Product Development: Innovation in spinal fusion devices, such as advanced biomaterials and minimally invasive technologies, is crucial for maintaining competitive advantage and market growth. Companies that invest in R&D are likely to lead the market.

Sustainability: Increasing focus on sustainability in medical device manufacturing is becoming important. Companies that incorporate eco-friendly practices and materials in their spinal fusion devices may attract environmentally conscious stakeholders and enhance their market position.

Conclusion

The spinal fusion devices market is expanding due to rising spinal disorder prevalence, technological advancements, and an aging population. While challenges such as high costs and regulatory hurdles exist, opportunities in emerging markets and innovation in product development present significant growth potential. Companies that focus on new product development and sustainability will be well-positioned to succeed in this dynamic market.

0 notes

rajasreenu10 · 4 months

Text

SaMD: Transforming Healthcare to Enhance Patient Outcomes

In today's rapidly evolving landscape of healthcare, technology plays an increasingly pivotal role in improving patient outcomes, enhancing diagnostics, and transforming treatment methodologies. One such technological innovation that has garnered significant attention is Software as a Medical Device (SaMD). Software as a Medical Device refers to software intended to be used for medical purposes without being part of a hardware medical device. It is designed to perform medical functions, whether for diagnosis, prevention, monitoring, treatment, or alleviation of disease. It encompasses a broad spectrum of applications, ranging from mobile health apps to sophisticated diagnostic algorithms and telemedicine platforms. By leveraging the power of software, it has the potential to bridge geographical barriers, streamline healthcare delivery, and empower both patients and healthcare providers with actionable insights derived from data.

This blog explores the Software as a medical device solution, focusing on its applications in remote patient monitoring (RPM), wireless Holter monitoring, cognitive anxiety management, scoliosis screening, and gamified therapy for ADHD.

Market on the Rise: The Growing Impact of SaMD The Software as a medical device market is expected to grow at a CAGR of 21.9% between 2020 and 2027. It has experienced rapid growth in recent years. It helps medical professionals predict, monitor, and diagnose diseases, allowing them to take preventive measures at the appropriate time. Because it does not require any hardware, it can use fast feedback loops for improvement. In addition, the advancement of technologies such as AI/ML, IoT, Telehealth, Cybersecurity, AR, and VR has accelerated the growth of software as a medical device. SaMD's Transformative Impact on Various Healthcare Aspects : The Software as a medical device market is experiencing phenomenal growth, fueled by its transformative impact on healthcare delivery. Here is how software as a medical device is transforming specific areas: Remote patient monitoring : Remote Patient Monitoring (RPM) transforms healthcare by allowing you to monitor vitals and physiological parameters remotely and in real-time. Software as a Medical Device is the backbone of this revolution, providing a secure and efficient platform to manage your patients' remote monitoring needs.

Real-time Tracking and Analytics: Software as a medical device platforms seamlessly collect vital signs and physiological data from wearables and biosensors. Advanced analytics engines analyze this data to identify trends, patterns, and potential health concerns. Customizable dashboards provide both you and the patient with clear visualizations of health data, facilitating informed decision-making.

Alerts and Notifications: It allows you to set personalized alerts for vital signs that exceed pre-defined thresholds. This enables prompt intervention and prevents potential complications. You also receive notifications of device malfunctions or errors, ensuring data integrity and system uptime.

Secure Communication: HIPAA-compliant Software as a medical device platforms prioritize patient data security. Multi-factor authentication and encryption ensure that only authorized personnel can access sensitive health information. Secure messaging features within the platform enable you to communicate with patients regarding treatment plans, medication adjustments, and any necessary follow-up actions.

Interoperability: The platforms designed for RPM seamlessly integrate with existing Electronic Health Records (EHR) systems. This eliminates the need for manual data entry, reduces errors, and ensures a complete view of the patient's medical history. They also facilitate data exchange with various wearable devices and biosensors, providing flexibility in choosing the most suitable monitoring tools for each patient's needs.

For more information click the below link : https://nu10.co/samd-transforming-healthcare-to-enhance-patient-outcomes/

#techsolutions #healthcare #nu10 #remote patient monitoring #wireless holter monitoring #machine learning #artificial intelligence #gaming therapy #adhd problems #startup #scoliosis #Scoliosis Screening

1 note · View note

techninja · 1 year

Text

Introduction

Scoliosis is a common musculoskeletal disorder characterized by an abnormal curvature of the spine. It affects millions of people worldwide, with varying degrees of severity, and often requires lifelong management. The Scoliosis Management Market is a dynamic sector of the healthcare industry that is constantly evolving to provide better treatment options for patients. In this article, we will explore the state of the Scoliosis Management Market, including current trends, advancements, key players, and the outlook for the future.

The Scoliosis Management Market Landscape

The global Scoliosis Management Market has experienced significant growth over the years, driven by various factors, including an increase in the prevalence of scoliosis, a growing awareness of the condition, and advancements in medical technology. Scoliosis management encompasses a wide range of treatment options, including bracing, physical therapy, and surgical interventions. This diversity in treatment modalities has led to a competitive and diverse market landscape.

Market Segmentation

The Scoliosis Management Market can be segmented into several categories based on the type of treatment and the age group of patients. The most common segments include:

1. Bracing: Orthopedic braces are widely used for managing scoliosis, especially in adolescents. These braces aim to prevent further progression of the curve and provide support to the spine during growth.

2. Surgery: Surgical interventions are considered in severe cases of scoliosis. Procedures like spinal fusion or implantation of growth-friendly devices are performed to correct the curvature.

3. Physical Therapy: Physical therapy and exercise programs are essential components of non-surgical scoliosis management. These techniques focus on strengthening the muscles around the spine and improving posture.

4. Others: This category includes alternative therapies, such as chiropractic care and acupuncture, which some patients may explore.

Key Players in the Scoliosis Management Market

Several companies play a significant role in the Scoliosis Management Market, manufacturing innovative products and technologies to improve patient outcomes. Some key players in the market include:

1. Medtronic

2. DePuy Synthes (a subsidiary of Johnson & Johnson)

3. Stryker Corporation

4. Orthofix Holdings, Inc.

5. NuVasive, Inc.

These companies produce a wide range of spinal implants, surgical instruments, and bracing devices. They are continuously investing in research and development to create better treatment options and more patient-friendly solutions.

Recent Advancements

The Scoliosis Management Market has witnessed several advancements in recent years:

1. 3D Printing: The use of 3D printing technology has revolutionized the design and manufacturing of scoliosis braces and spinal implants. Customized braces, tailored to the unique needs of each patient, are now possible, leading to improved patient comfort and treatment effectiveness.

2. Growth-Friendly Implants: Innovative growth-friendly devices are now available for pediatric patients. These implants can be adjusted as a child grows, reducing the need for frequent surgeries and improving overall outcomes.

3. Minimally Invasive Surgery: Surgeons are increasingly using minimally invasive techniques for scoliosis correction. These procedures result in smaller incisions, reduced post-operative pain, and faster recovery times.

4. Telemedicine: The COVID-19 pandemic accelerated the adoption of telemedicine in scoliosis management. Patients can now receive virtual consultations, reducing the need for in-person visits.

Future Outlook

The Scoliosis Management Market is expected to continue growing as the understanding of scoliosis and its treatment options improves. Advancements in technology, patient-specific approaches, and a focus on non-surgical methods are likely to shape the future of scoliosis management. Additionally, increased awareness and early detection will lead to better outcomes for scoliosis patients.

In conclusion, the Scoliosis Management Market is a dynamic sector of the healthcare industry that has witnessed significant growth and technological advancements. Patients with scoliosis now have access to a wider range of treatment options, tailored to their specific needs. As research and innovation continue, the future holds promise for further improvements in the management of this condition, ultimately enhancing the quality of life for those affected by scoliosis.

The Global Scoliosis Management Market: Key Players and Growth Opportunities

0 notes

jean-perry · 2 years

Text

0 notes

marketinsight · 3 years

Link

Scoliosis Management Market is forecasted to value over USD 3.3 billion by 2025 end at a CAGR of over 3.5% during the forecast period 2020 to 2027.

#Scoliosis Management Market #Scoliosis Management Market Trends #Scoliosis Management Market Share #Scoliosis Management Market Size

0 notes

wiseguyreport1221 · 3 years

Link

0 notes

marketreports-world · 3 years

Text

Spinal Traction Market Segmentation, Applications, Dynamics and Overview By 2027

Spinal Traction Market Information: By Type (Manual Spinal Traction, Mechanical Spinal Traction), Applications (Slipped Discs, Bone Spurs, Degenerative Disc Disease, Herniated Discs, Facet Disease, Sciatica, Foramina Stenosis, Pinched Nerves), Devices (Continuous Traction, Gravity-Dependent Traction, Manual Traction) - Forecast till 2027

Market Synopsis

According to a new report by Market Research Future (MRFR), the global spinal traction market is expected to reach USD 6.0 billion by the end of 2023. The market is envisaged to witness a steady growth to expand at 7.7 % CAGR over the forecast period (2017-2023) owing to the growing geriatric population. Spinal traction devices are used to stabilize and decompress the spine for treating several spinal disorders and orthopedic conditions like bone fractures, muscle contracture, and bone deformities like kyphosis, scoliosis, and lordosis. These devices are also used in treating low back pain and muscle spasms. Spinal traction devices are also used to prepare patients for surgical procedures like interbody fixation, endoscopic spine surgery, vertebral compression fracture repair, and interspinous fixation.

Future Drivers and Constraints

Increasing production number of spinal surgery, implants, and ongoing researches for improving the quality of care are expected to create attractive growth opportunities for the market globally. With the increasing cases of trauma and spinal cord diseases, growing geriatric population, increase in the number of spinal surgeries, screening and awareness, and developing healthcare are some of the factors propelling the market growth over the review period.

Also, the shift in the preference among patients and surgeons for adopting minimally invasive (MI) surgery over traditional surgeries have resulted in the development of advanced spinal implants. The rising number of clinical trials of latest technology implants is also propelling the market growth over the assessment period.

Innovation has remained the best strategy with companies focusing on developing new devices which can offer better treatment and diagnostic to various types of spine conditions. Wireless sensor technology is one of the latest researches with advanced products connected to external devices for analysis and healing progress.

Meanwhile, costly devices, lack of experimental clinical data in medical treatment, risk related after surgery which comprises risk of damage and infection to the spine, and demand for minimally invasive procedures is assessed to hamper the growth of the market over the forecast period.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1902

Global Spinal Traction Market Segmentation

The global market for spinal traction has been segmented on the basis of diagnosis, type, treatment, end-users, and region.

The market has been segmented into mechanical spinal traction and manual spinal traction based on types. The market has been segmented into herniated discs, sciatica, facet disease, slipped discs, bone spurs, foraminal stenosis, pinched nerves, and degenerative disc disease, based on applications. The market has been segmented into gravity-dependent traction, manual traction, and continuous traction based on devices.

The market has also been segmented into academic and research, hospitals and clinics, and others based on end-users. Among these, the segment for hospital dominated the global market for spinal traction and is predicted to maintain its dominance over the assessment period.

Regional Analysis

Geographically, the market for spinal traction has been spanned across regions such as North America, the Middle East and Africa, Europe, and Asia Pacific.

The North American region is anticipated to hold the largest market share due to the high expenditure on healthcare. Also, adoption of medical devices and new diagnostics in the U.S. is also expected to drive the market in this region. Moreover, the presence of large hospital networks and major healthcare companies in the developed countries is propelling the market growth over the assessment period.

Europe holds the second largest position after North America, owing to the penetration of strong healthcare and high income in this region. Countries such as France and Germany are expected to lead the market growth in the European region. The UK is anticipated to emerge as the fastest growing market over the review period due to the presence of strong pharmaceutical industry.

Asia Pacific is estimated to grow rapidly over the assessment period. India and China are likely to lead the market owing to the huge unmet requirement and fast-growing healthcare sector over the assessment period. Moreover, South East Asian countries like India, China, and Malaysia are estimated to contribute to the market growth. Also, increasing penetration of healthcare insurance in the Asia Pacific region is anticipated to spur the market growth in this region.

Moreover, the UAE and Saudi Arabia are anticipated to drive the Middle East and African market. The African region is expected to witness moderate growth due to poor political and economic conditions.

Industry News

Natural compounds derived from Australian plants have been found to stimulate cells and are useful for transplantation to repair injuries in the spinal cord. The results have been published in the Scientific Reports by a team of scientists recently at the Menzies Health Institute Queensland and Griffith Institute for Drug Discovery.

Competition Analysis

The prominent players operating the spinal traction market are Stoll Medizintechnik GmbH, Spinal Designs International Inc., Saunders Group Inc., SpineRx Technology, VAX-D Medical Technologies LLC., Scrip, Inc. BTL, North American Medical (NAM) Corporation, Spinetronics, LLC, Dentsply International, Medtronic Inc., CERT Health Sciences LLC, Hill Laboratories Company, and others.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/spinal-traction-market-1902

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Global Veterinary Pain Management Market Research Report—Forecast till 2027

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

#Spinal Traction Market

0 notes

market-research-future · 3 years

Text

Negative Pressure Wound Therapy Market Size, Share, Demand and Growth Till 2027

Global Negative Pressure Wound Therapy Market: Segmental Analysis

The global negative pressure wound therapy market has been segmented on the basis of wound type, product type, end-user, and region.

By mode of product type, the global negative pressure wound therapy market has been segmented into single-use negative pressure wound therapy devices, conventional negative pressure wound therapy devices, and accessories. Among these, the conventional segment is considered to account for the largest market share owing to the ability of conventional negative pressure wound therapy devices to manage severe wound exudates.

By mode of wound type, the global negative pressure wound therapy market has been segmented into ulcers, surgical and traumatic wounds, and burns. Among these, the ulcers segment has been further sub-segmented into venous ulcers, diabetic foot ulcers, pressure ulcers, and others. Surgical and traumatic wounds account for the largest market share owing to the increasing prevalence of such wounds coupled with an increasing spending on surgical and chronic wounds.

By mode of end-users, the global negative pressure wound therapy market has been segmented into home care settings, hospitals, and others. Among these, the hospitals segment is considered to account for the largest market share owing to the high number of surgeries performed in hospitals.

Market Highlights

The global negative pressure wound therapy market is predicted to register 6.7% CAGR during the forecast period (2018-2023) owing to the rising prevalence of chronic diseases, asserts Market Research Future (MRFR). NPWT, also known as negative-pressure wound therapy is referred to as a sealed wound-care system, majorly indicated for acute complicated wounds and large chronic persistent wounds. The system comprises a foam dressing and a controlled pump which drains out the wound. Negative pressure is applied around the wound which promotes healing. Such devices are used to manage chronic and acute wounds like venous ulcers, diabetic ulcers, pressure ulcers, arterial ulcers, and first- and second-degree burns. The therapy heals wound by applying vacuum through a sealed wound dressing. The vacuum further draws out the debris and fluid from the wound and helps to increases blood supply to the affected area.

Drivers and Constraints Impacting the Market

With rising prevalence of chronic diseases such as obesity and diabetes, increasing spending on surgical and chronic wounds, and growing causalities caused by accidents and trauma, the global negative pressure wound therapy is considered to propel during the forecast period. For instance, as per the Centers for Disease Control and Prevention, around 2.8 million people were hospitalized due to injuries in 2015. The augmenting rate of caesarean sections in elderly mothers is likely to accelerate the post-operative use of NPWT devices. Moreover, with the growing use of simplified single-use devices, the negative pressure wound therapy market is considered to propel during the forecast period. Additionally, the rise of hospitals with enhanced services for wound care is further anticipated to trigger the demand for NPWT across the globe.

On the flip side, the high cost associated with the therapy over conventional wound therapy coupled with a dearth of trained healthcare professionals are some of the major concerns anticipated to impede the market growth during the appraisal period. Also, absence of proof of clinical adequacy is predicted to restrict the market growth in the coming years.

Access Report @ https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-651

Regional Insights Geographically, the negative pressure wound therapy market span across regions namely, Europe, Americas, Asia-Pacific, and the Middle East and Africa.

Among all the regions, America is anticipated to dominate the global negative pressure wound therapy market. The growth is attributed to the presence of well-developed healthcare sector, augmenting rate of accidents, increasing prevalence of diabetes, and rising expenditure of the healthcare sector.

The European region is presumed to account for the second largest position owing to the increasing prevalence of chronic diseases and accelerating occurrences of burn cases and accidents. The Asia-Pacific region is anticipated to exhibit the fastest growth rate due to the presence of a huge population base of diabetic patients coupled with the rising developments in the healthcare segment.

Industry Updates December 07, 2018: An Acelity Company, KCI has recently announced the launch of the V.A.C.RX4 Therapy System in the United States. The V.A.C.RX4 System has been initially developed at the request of the U.S. Department of Defense and U.S. Air Force in order to help the military personnel treat multiple battlefield wounds with a single negative pressure wound therapy.

Competitive Dashboard The prominent players operating the global negative pressure wound therapy market are Lohmann & Rauscher International GmbH & Co. Kg, Talley Group, Genadyne, Smith & Nephew, Medela, DeRoyal Industries Inc., Mölnlycke Health Care AB (A Subsidiary of Investor AB), ACELITY L. P. Inc., Cardinal Health, and ConvaTec Group Plc.

Browse More Related Reports at:

Human Insulin Market by Type, Share, Growth and Analysis – 2027 | MRFR

Durable Medical Equipment Market Size, Share, Trends and Industry Analysis to 2027

Scoliosis Treatment Market Overview, Share Analysis and Global Forecast to 2027

0 notes

insightslicelive · 2 years

Text

Scoliosis management Market 2022: Will Promptly Grow in Near Future 2032 | Chaneco, Original Bending Brace, Orthotech

An overview of the market segment, size, share, sectional analysis, and revenue forecast, as well as a complete analysis, are included in the Scoliosis management Market study. It engulfs micro and macroeconomic factors, industry trends, dynamics, and the strengths and weaknesses of the top competitors. It also includes details on sales channels, distributors, traders, and dealers, as well as…

View On WordPress

#Scoliosis management #Scoliosis management manufacturing companies #Scoliosis management market #Scoliosis management market size #Scoliosis management market trends #Scope of Scoliosis management industry

0 notes

speedylightheart · 4 years

Text

US Scoliosis Treatment Market Analysis, Growth, demand, Latest Trend and Forecast Report 2025

Increasing prevalence of scoliosis surgeries, rising demand for spine surgeries and the growing prevalence of musculoskeletal disorder are some of the major factors driving the growth of the market.

Global Scoliosis Treatment Market is valued at USD 2519.8 Million in 2018 and expected to reach USD 3342.7 Million by 2025 with the CAGR of 4.12% over the forecast period.

Scope of Global Scoliosis Treatment Market Report-

Scoliosis is an abnormal curve in the spinal cord. Depending on the severity of the curve and the risk of it deteriorating, scoliosis can be treated with bracing or surgery. There is no cure for scoliosis, but the pain can be alleviated. Scoliosis is a spine disorder in which the spine moves toward becoming S or C-shaped. The essential explanations behind the event of the scoliosis are having the disorders, for example, muscular dystrophy and cerebral paralysis. Scoliosis is most normal in those over around 10 years old. The primary reasons for the occurrence of the scoliosis are having the disorders such as cerebral palsy and muscular dystrophy. In the early stage, scoliosis is minor, but if not treated may lead to severe deformities. In extreme cases, the abnormal curvature can progress and have an effect on the heart or the lung functioning in the thoracic spine.

Global Scoliosis Treatment Market report is segmented based on disease, product, distribution channel and region & country level. Based upon disease, scoliosis treatment market is classified into infantile idiopathic scoliosis and adolescent idiopathic scoliosis. Based upon product, scoliosis treatment market is classified into cervical thoracic lumbar sacral orthosis (CTLSO), thoracolumbosacral orthosis (TLSO) and lumbosacral orthosis (LSO). Based upon distribution channel, scoliosis treatment market is classified into hospitals & clinics, retail pharmacies and online pharmacies.

The regions covered in this scoliosis treatment market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of scoliosis treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players of Global Scoliosis Treatment Market Report-

Global Scoliosis Treatment market report covers prominent players like Chaneco, Orthotech, L.A. Brace, DJO, LLC, Lawall Prosthetics and Orthotics, Aspen Medical Products, C H Martin Company, Spinal Technology, Inc., Wellinks, Inc., Boston Orthotics & Prosthetics, Original Bending Brace, Trulife, Össur, Wilmington Orthotics & Prosthetics, Inc., Horton's Orthotics & Prosthetics, NuVasive Inc., NYQ, Optec USA, Inc., Ortholutions GmbH & Co. KG, Pro-Tech Orthopedics and others.

Global Scoliosis Treatment Market Dynamics–

Increasing incidences of cerebral palsy and muscular dystrophy leading to scoliosis will serve to have a positive impact on the market growth. According to a study published in Journal of Spine Surgery, scoliosis occurs among 64% of patients suffering from cerebral palsy. Genetic predisposition coupled with increasing adoption of sedentary lifestyle and lack of physical activity is some of the major factors that lead to development of scoliosis. In addition, rising surgical procedures in developed nations, utilization of 3D printing technology, higher usage for customized braces, new product launches, and maximum utilization of advanced braces such as cervical thoracic lumbar sacral orthosis brace and thoracolumbosacral orthosis brace are also anticipated to foster the market growth during the forecast period. However, the high cost of treatment or procedures and limited understanding of the disorder and available treatment options are expected to curb the growth of the scoliosis treatment market. Moreover, several untapped regions can provide lucrative opportunity for the further market growth.

Global Scoliosis Treatment Market Regional Analysis–

North America is dominating the scoliosis treatment market with the potential rate in terms of revenue due to growing demand for spine surgeries coupled with the growing incidence of musculoskeletal disorders, higher adoption of branded support braces, increasing awareness and programs held by top trained and skilled professionals in this region. In addition, maximum reimbursement coverage, higher patient safety and the presence of top key manufacturers & sophisticated healthcare infrastructure in the U.S. and Canada are also fostering the market growth in this region. For instance, as per the National Scoliosis Foundation (NSF), around 2% to 3% of the general population, approximately 7 million people, encounter scoliosis in the U.S.

Asia Pacific is anticipated to grow at a highest CAGR over forecast period due to rapidly evolving healthcare infrastructure and increasing awareness among people in this region. Indian scoliosis market is expected to show lucrative growth over the analysis timeframe. Presence of large patient pool suffering from scoliosis is the key factor that will drive the scoliosis industry growth in the country. Furthermore, growing awareness among people regarding scoliosis treatment, increasing adoption of advanced technologies and increasing healthcare expenditure are also anticipated to augment market growth in this region.

Key Benefits for Global Scoliosis Treatment Market Report–

Global market report covers in depth historical and forecast analysis.

Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Scoliosis Treatment Market Segmentation:–

By Disease:

Infantile idiopathic scoliosis

Adolescent idiopathic scoliosis

By Product:

Cervical thoracic lumbar sacral orthosis (CTLSO)

Thoracolumbosacral orthosis(TLSO)

Lumbosacral orthosis (LSO)

By Distribution Channel:

Hospitals & clinics

Retail pharmacies

Online pharmacies

By Regional & Country Analysis:

North America

US.

Mexico

Canada

Europe

France

Germany

Italy

Asia Pacific

China

Japan

India

Southeast Asia

South America

Brazil,

Argentina

Columbia

The Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

About Us:

Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

0 notes

techninja · 1 year

Text

Telemedicine and Remote Monitoring: Transforming Scoliosis Management Market

Introduction

Scoliosis, a complex spinal deformity characterized by an abnormal curvature of the spine, affects millions of people worldwide, predominantly adolescents. The Scoliosis Management Market has witnessed remarkable advancements in recent years, driven by technological innovations, increased awareness, and a growing patient population. This article delves into the current state of the scoliosis management market, highlighting key trends, challenges, and growth opportunities.

Market Overview

The global scoliosis management market has been steadily expanding, with a compound annual growth rate (CAGR) of approximately 5.6% in the last few years. This growth can be attributed to several factors, including rising scoliosis incidence rates, a surge in surgical interventions, and advancements in non-surgical treatment options. Additionally, greater awareness of scoliosis and early diagnosis have played pivotal roles in driving market expansion.

Key Trends and Innovations

1. Minimally Invasive Surgical Techniques: Traditional scoliosis surgeries were invasive and involved long recovery periods. However, advancements in minimally invasive surgical techniques, such as thoracoscopic and laparoscopic procedures, have gained prominence. These procedures reduce postoperative pain and recovery time, making them more attractive to patients.

2. 3D Printing Technology: 3D printing has revolutionized scoliosis management by enabling the creation of customized spinal implants and orthotic devices. This technology allows for greater precision in correcting spinal deformities, reducing the risk of complications and improving patient outcomes.

3. Bracing Innovations: Orthopedic bracing is a common non-surgical approach for scoliosis management. Recent innovations have led to more comfortable and adjustable braces, enhancing patient compliance. These braces are often made using lightweight, breathable materials for increased comfort during long-term wear.

4. Telemedicine and Remote Monitoring: The COVID-19 pandemic accelerated the adoption of telemedicine in healthcare, including scoliosis management. Patients can now consult with specialists remotely, reducing the need for in-person visits. Remote monitoring devices also allow physicians to track a patient's progress more effectively.

Challenges in Scoliosis Management

While the scoliosis management market shows promise, it faces certain challenges:

1. Limited Access to Healthcare: In some regions, especially in developing countries, access to specialized scoliosis care remains limited. This results in delayed diagnosis and treatment, impacting patient outcomes.

2. High Treatment Costs: Advanced surgical techniques and innovative treatments can be costly. Many patients struggle with the financial burden of scoliosis management, making affordability a significant concern.

3. Patient Compliance: Long-term management often requires strict adherence to bracing protocols and physical therapy. Ensuring patient compliance can be challenging, particularly among adolescents.

4. Surgical Risks: While minimally invasive procedures have improved outcomes, all surgeries carry inherent risks. Surgeons must carefully assess each patient's case to determine the most appropriate treatment approach.

Growth Opportunities

Despite the challenges, the scoliosis management market presents numerous growth opportunities:

1. Global Expansion: The market can expand by increasing access to scoliosis care in underserved regions. Initiatives such as medical missions and telemedicine programs can help bridge the gap.

2. Patient-Friendly Solutions: Innovations focused on patient comfort and convenience, such as wearable devices for monitoring and more aesthetically pleasing orthotic designs, can boost patient compliance and market growth.

3. Research and Development: Continued research into non-surgical treatment options and better understanding the underlying causes of scoliosis can lead to breakthroughs in management strategies.

4. Healthcare Policy Changes: Changes in healthcare policies and reimbursement structures can make scoliosis management more affordable for patients.

Conclusion

The scoliosis management market is poised for continued growth, driven by technological advancements, increasing awareness, and a growing patient population. However, challenges related to access, affordability, and patient compliance persist. By addressing these challenges and capitalizing on opportunities for innovation and expansion, the scoliosis management market can offer improved outcomes and a better quality of life for individuals living with this spinal condition.

0 notes

kritikarehani · 4 years

Text

Chronic Lower Back Pain (CLBP) Market Share & Size

DelveInsight’s ‘Chronic Lower Back Pain (CLBP) Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Chronic lower back pain (CLBP), historical and forecasted epidemiology as well as the Chronic lower back pain (CLBP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Chronic Lower Back Pain (CLBP) Disease Understanding and Treatment Algorithm

Chronic Low Back Pain (CLBP) Overview

Chronic low back pain (CLBP) is defined as pain that persists for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain. Low back pain is very common and at one point everyone must have faced this problem. Lower back pain that is long-term (for more than 3 months) is called chronic low back pain, this condition might originate from an injury, disease, or stress on different structures of the body, and pain may vary significantly and maybe felt as bone pain, nerve pain, or muscle pain. The intensity of the pain also ranges from mild to severe. CLBP is the second leading cause of disability worldwide being major welfare and economic problem. The prevalence of CLBP in adults has increased significantly in the last decade and is continuously increasing vividly in the aging population. This condition affects men and women in all ethnic groups equally. This disease also leads to stress, depression, and anxiety. CLBP affects physically and psychologically and creates a significant amount of economic burden due to loss of function, loss of work productivity, treatment costs, and disability payments.

The probable causes of CLBP are the curve of the spine, such as scoliosis or kyphosis, medical problems (fibromyalgia or rheumatoid arthritis), and piriformis syndrome (a pain disorder involving a muscle in the buttocks called the piriformis muscle). Many people with CLBP have arthritis or tear of the spine due to heavy exercise, herniated disk, or due to surgery. A herniated disc is the part of the spinal disk pushed onto the nearby nerve. Usually, these disks provide space and cushion in the spine and the loss of movement can be seen as overtime if these disks dry out and become thinner and brittle. Spinal Stenosis is the condition that arises if the spaces between the spinal nerves and spinal cord become more narrowed.

Chronic Low Back Pain (CLBP) Diagnosis

The diagnosis and evaluation of CLBP are very important to reduce or to rule out the risk factors due to severe injury. The first recommendation is a thorough physical examination by a well-trained physician. CLBP testing may include blood tests, radiography (X-ray imaging), bone scans, computed tomography (CT) scans, magnetic resonance imaging (MRI), diagnostic injections, bone scan, electromyography (EMG), lumbar radiography, and many other specialized tests.

continued in the report…..

Chronic Low Back Pain (CLBP) Treatment

CLBP is the most prevalent chronic pain condition and the second most common cause of disability in the US, after arthritis or rheumatism. CLBP may be nociceptive or neuropathic or include both components. The presence of a neuropathic component is related to the more intense pain of longer duration, and a higher prevalence of co-morbidities. The actual mechanism and cause of CLBP are still unknown and due to this situation, there are no universally accepted treatment guidelines and the management of the treatment is limited. If the source of the pain is not known or can not be treated, the best option remains is to reduce the flare-ups and making the pain manageable with nonsurgical treatments. There are non-surgical treatments (physical therapy, diet, meditation, lifestyle modifications) Injection-based Treatments, pharmacologic treatments.

For some patients, CLBP can be relieved by single-agent therapy, but as both nociceptive and neuropathic mechanisms are often present, combining agents with different mechanisms of action is a rational approach Analgesics, anti-inflammatory drugs, muscle relaxants, and other medications can be used to help control chronic back pain. However, most come with unwanted side effects and are not intended for prolonged use. Opioid medication should not be used without a physician’s recommendation.

The use of non-opioid analgesics such as acetaminophen (APAP), non-steroidal anti-inflammatory drugs (NSAIDs), or cyclooxygenase-2 (COX-2) inhibitors for initial management for LBP. The use of muscle relaxants should be avoided in patients with CLBP. Treatment of mild CLBP often begins with the use of NSAIDs and mild non-opioid analgesics, while more potent opioid analgesics are reserved for the pain of moderate-to-severe intensity.

Browse full report @ https://www.delveinsight.com/sample-request/chronic-lower-back-pain-clbp-market

Chronic Low Back Pain (CLBP) Epidemiology

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Population of Chronic Lower Back Pain, Total Diagnosed Prevalent Population of Chronic Lower Back Pain, Gender- Specific Diagnosed Prevalence of Chronic Lower Back Pain, Age - Specific Diagnosed Prevalence of Chronic Lower Back Pain, Severity Specific Diagnosed Prevalence of Chronic Lower Back Pain, Number of CLBP Patients on Prescription Medications by different Class and Number of CLBP Patients on Opioids by low dose, high dose and Overdose scenario of CLBP in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.

Key Findings

· This section provides glimpses of the Chronic low back pain (CLBP) epidemiology in the 7MM.

· As per DelveInsight’s analysis, the total Prevalent Population of Chronic low back pain (CLBP) in the 7MM was found to be 73,802,461 in 2017.

· The estimates show higher prevalence of Chronic low back pain (CLBP) in the United States with 33,821,043 cases in 2017.

· Amongs EU5, United Kingdom show higher prevalence of Chronic low back pain (CLBP) followed by Germany and France, Italy and Spain respectively.

· As per DelveInsight’s analysis, a higher percentage of diagnosed prevalence was observed for females, in comparison to males, in all the 7MM countries, except Japan, wherein males occupy a larger patient pool than females

· Among the EU5 countries, United Kingdom had the highest diagnosed prevalent population of CLBP with 3,517,443 cases, followed by Germany and the France. On the other hand, Spain had the lowest diagnosed prevalent population.

Country-wise Chronic low back pain (CLBP) Epidemiology

The epidemiology segment also provides the Chronic low back pain (CLBP) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Chronic Low Back Pain (CLBP) Drug Chapters

The drug chapter segment of the Chronic low back pain (CLBP) report encloses the detailed analysis of CLBP marketed drugs, mid phase and late stage (phase III) pipeline drugs. It also helps to understand the Chronic low back pain (CLBP) clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details of each included drug and the latest news and press releases.

Chronic Low Back Pain (CLBP) Marketed Drugs

1. Cymbalta: Eli Lilly and Company

Cymbalta (Duloxetine) is a serotonin and norepinephrine reuptake inhibitor (SNRI) developed by Eli Lilly and Company. Serotonin and norepinephrine hormones present in the brain and spinal cord and are believed mediate core mood symptoms and help regulate the perception of pain. Duloxetine hydrochloride is the active ingredient of this medication. The drug is believed to be related to an increase in the action of serotonin and norepinephrine in the brain and spinal cord. People who suffer from CLBP experiences various range of pain and often struggle to find the right medication. The drug is been approved for the management of various other indication like Neuropathic Pain, Osteoarthritis, Generalized Anxiety Disorder, Major Depressive Disorder, Fibromyalgia, Diabetic Kidney Disease, etc.